BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18504732)

  • 1. MRI measurement of change in vascular parameters in the 9L rat cerebral tumor after dexamethasone administration.
    Ewing JR; Brown SL; Nagaraja TN; Bagher-Ebadian H; Paudyal R; Panda S; Knight RA; Ding G; Jiang Q; Lu M; Fenstermacher JD
    J Magn Reson Imaging; 2008 Jun; 27(6):1430-8. PubMed ID: 18504732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor.
    Ewing JR; Brown SL; Lu M; Panda S; Ding G; Knight RA; Cao Y; Jiang Q; Nagaraja TN; Churchman JL; Fenstermacher JD
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):310-20. PubMed ID: 16079791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility and relative stability in magnetic resonance imaging indices of tumor vascular physiology over a period of 24h in a rat 9L gliosarcoma model.
    Nagaraja TN; Elmghirbi R; Brown SL; Schultz LR; Lee IY; Keenan KA; Panda S; Cabral G; Mikkelsen T; Ewing JR
    Magn Reson Imaging; 2017 Dec; 44():131-139. PubMed ID: 28887206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors.
    Ostergaard L; Hochberg FH; Rabinov JD; Sorensen AG; Lev M; Kim L; Weisskoff RM; Gonzalez RG; Gyldensted C; Rosen BR
    J Neurosurg; 1999 Feb; 90(2):300-5. PubMed ID: 9950501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps.
    Badruddoja MA; Krouwer HG; Rand SD; Rebro KJ; Pathak AP; Schmainda KM
    Neuro Oncol; 2003 Oct; 5(4):235-43. PubMed ID: 14565159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics.
    Jost G; Pietsch H; Grenacher L
    Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma.
    Bastin ME; Carpenter TK; Armitage PA; Sinha S; Wardlaw JM; Whittle IR
    AJNR Am J Neuroradiol; 2006 Feb; 27(2):402-8. PubMed ID: 16484419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
    Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
    Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of perfusion in rat cerebral 9L tumor after nicotinamide administration.
    Brown SL; Ewing JR; Kolozsvary A; Butt S; Cao Y; Kim JH
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):627-33. PubMed ID: 10078649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging.
    Armitage PA; Schwindack C; Bastin ME; Whittle IR
    Magn Reson Imaging; 2007 Apr; 25(3):303-10. PubMed ID: 17371718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters.
    Quarles CC; Krouwer HG; Rand SD; Schmainda KM
    Technol Cancer Res Treat; 2005 Jun; 4(3):245-9. PubMed ID: 15896079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruption.
    Blanchette M; Tremblay L; Lepage M; Fortin D
    J Cereb Blood Flow Metab; 2014 May; 34(5):820-6. PubMed ID: 24517973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
    Hirschberg H; Wu GN; Madsen SJ
    Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results.
    Larsson C; Kleppestø M; Rasmussen I; Salo R; Vardal J; Brandal P; Bjørnerud A
    J Magn Reson Imaging; 2013 Apr; 37(4):818-29. PubMed ID: 23086710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
    Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
    Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI estimation of contrast agent concentration in tissue using a neural network approach.
    Bagher-Ebadian H; Nagaraja TN; Paudyal R; Whitton P; Panda S; Fenstermacher JD; Ewing JR
    Magn Reson Med; 2007 Aug; 58(2):290-7. PubMed ID: 17654573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative estimation of dynamic contrast enhanced MRI parameters in rat brain gliomas using a dual surface coil system.
    Pickup S; Chawla S; Poptani H
    Acad Radiol; 2009 Mar; 16(3):341-50. PubMed ID: 19201363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
    Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
    Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.